New Listing Alert - Frequency Exchange: Wearable Technology to Help Overcome General Wellness Issues

October 21, 2022

Stocks to Invest in: Wearable Devices

Fremedica Technologies Inc. is a wholly owned subsidiary of Frequency Exchange Corp. The Company markets a frequency emitter that delivers the benefits of bioresonance through a lightweight, wearable device. The Fremedica product includes a special package of frequencies that support the immune system and speed recovery from Lyme disease. Lyme is the fastest-growing vector borne illness in North America. Fremedica was established in 2016 and has enjoyed rapid growth to currently serve over 1,000 customers.

Frequency Exchange is focused on the development and commercialization of a Frequency Delivery System that you wear.

Their wearable product, Nikki, delivers frequencies into the body to target and help general wellness issues.

The company is now listing on the TSXV under the symbol FREQ.

For more information on Frequency Exchange Corp. (TSX.V: FREQ) please click the investor request info button.


You might also like

Healthcare
Lexaria Bioscience: Revolutionizing GLP-1 Drug Delivery with Patented Oral Platform

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

Healthcare
Lexaria Bioscience: Advancing GLP-1 Drug Delivery with DehydraTECH™ Technology

Lexaria Bioscience’s DehydraTECH™ technology aims to redefine oral drug delivery, focusing on faster absorption and improved efficacy, with a promising impact on the GLP-1 pharmaceutical market.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!